Novel factor-based symptom scores in treatment resistant schizophrenia: Implications for clinical trials

Neuropsychopharmacology

Volumn 26, Issue 4, 2002, Pages 537-545

  McMahon, Robert P ^a   Kelly, Deanna L ^a   Kreyenbuhl, Julie ^a,c   Kirkpatrick, Brian ^a   Love, Raymond C ^a,b   Conley, Robert R ^a  

^a MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

^b Department of Pharmacy Practice and Science ^*  (United States)

^c UNIVERSITY OF MARYLAND   (United States)

Author keywords

Factor structure; Schizophrenia; Symptoms; Syndromes

Indexed keywords

CLOZAPINE;

ADOLESCENT; ADULT; AGED; ANXIETY; ARTICLE; CONTROLLED STUDY; DATA BASE; DEPRESSION; DISORIENTATION; FACTORIAL ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; PRIORITY JOURNAL; RATING SCALE; SCHIZOPHRENIA; SYMPTOM; VALIDATION PROCESS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; CLINICAL TRIALS; CLOZAPINE; DATABASES, FACTUAL; DRUG RESISTANCE; FACTOR ANALYSIS, STATISTICAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MARYLAND; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RESEARCH DESIGN; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0036200170     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(01)00387-6     Document Type: Article

References (28)

1. Scale for the Assessment of Negative Symptoms (SANS): Conceptual and theoretical foundations
2. The distinction of positive and negative symptoms: The failure of a two-dimensional model
3. A longitudinal study of symptom dimensions in schizophrenia: Prediction and patterns of change
4. Cerebral morphometry and clozapine treatment in schizophrenia
5. Domains of psychopathology: An approach to the reduction of heterogeneity in schizophrenia
6. Antipsychotic drugs: Clinical pharmacology and therapeutic use
7. Clozapine eligibility among state hospital patients
8. Stability of positive and negative symptom constructs during neuroleptic treatment of schizophrenia
9. Empirical evaluation of the factorial structure of clinical symptoms in schizophrenia: Effects of typical neuroleptics on the Brief Psychiatric Rating Scale
10. Clozapine for the treatment resistant schizophrenic
11. Stability of the five factor structure of the Positive and Negative Symptom Scale (PANSS)
12. Prediction of outcome in first-episode schizophrenia
13. Variability in BPRS definitions of positive and negative symptoms
14. Treatment resistant chronic psychopathology and CT scans
15. The Brief Psychiatric Rating Scale (BPRS): Recent developments in ascertainment and scaling
16. High-dose chlorpromazine therapy in chronic schizophrenia
17. Schizophrenic syndromes and clozapine response in treatment resistant schizophrenia
18. Predictors of response to neuroleptic treatment in schizophrenia
19. The three-syndrome model of schizophrenia: Meta-analysis of an artefact
20. Content and quality of 2000 clinical trials in schizophrenia over 50 years
21. Are biochemical markers for treatment resistant schizophrenia state dependent or traits?